gTLD	Full Legal Name	E-mail suffix	Detail
.SCA	SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ)	valideus.com	View

The registry will be rigorously controlled by authorised Svenska Cellulosa Aktiebolaget SCA personnel but it is predicted that it will also benefit the following stakeholders:

• Our customers: a new .SCA registry will benefit them because it will be a signpost to authentic, accessible information about the products within the Svenska Cellulosa Aktiebolaget SCA family.
• Our employees: a new gTLD will be perceived as demonstrating that Svenska Cellulosa Aktiebolaget SCA is at the forefront of developments in internet technology. It will also reinforce our brand worldwide providing a more secure communication channel.

i. What is the goal of your proposed gTLD in terms of areas of speciality, service levels reputation?

The integrity of our Svenska Cellulosa Aktiebolaget SCA brand is of paramount importance to us. This will be reflected in the treatment of the new gTLD, the goal for which is to position the company to exploit the latest internet advances in order to enhance our brand and reputation further. The new registry will be designed so that it is 100% ICANN compliant and will be run in a highly professional manner to reflect our standing as a leader in our field.

ii. What do you anticipate your proposed gTLD will add to the current space in terms of competition, differentiation or innovation?

We are eager to operate a registry with shorter domain names that are universally applicable across the globe in all our markets. We feel it offers clarity and will enable our customers to place their trust in our registry which will also provide opportunities for enhanced communication.

We look forward to utilising our new registry in conjunction with our current domains and are keen to market under the term .SCA if the new gTLD process is a success. It enables brands to leave behind complex naming hierarchies inherent in country code extensions.

iii. What goals does your proposed gTLD have in terms of user experience?

We want our customers to know they are in a trusted and authentic destination once they arrive at the new gTLD. Above all, we want them to be confident that they will receive accurate information and that any sensitive personal details they provide will be protected. In this way, we believe our application is in the public interest.

iv. Provide a complete description of the applicant’s intended registration policies in support of the goals above

Svenska Cellulosa Aktiebolaget SCA is the operator of the .SCA registry. The Svenska Cellulosa Aktiebolaget SCA Domain Name Management team is responsible for the development, maintenance and enforcement of the Svenska Cellulosa Aktiebolaget SCA Domain Management Policy. This policy defines the rules associated with eligibility and domain name allocation, sets out the license terms governing the use of a .SCA domain name and describes the dispute resolution policies for the Svenska Cellulosa Aktiebolaget SCA gTLD. The policy will be updated and revised regularly to reflect Svenska Cellulosa Aktiebolaget Svenska Cellulosa Aktiebolaget SCAʹs commercial and strategic interests and, where appropriate, ICANN consensus policies.

Registration of a .SCA domain name will be undertaken in four steps: Eligibility Confirmation, Naming Convention Check, Acceptable Use Review, and finally Registration. All domains in the .SCA registry will remain the property of Svenska Cellulosa Aktiebolaget SCA.

Each applied for character string must conform to the .SCA rules of eligibility. Each .SCA name must:

• Be at least 3 characters and no more than 63 characters long
• Not contain a hyphen on the 3rd and 4th position (tagged domains)
• Contain only letters (a-z), numbers (0-9) and hyphens or a combination of these
• Start and end with an alphanumeric character, not a hyphen
• Not match any character strings reserved by ICANN
• Not match any protected country names or geographical terms

Internationalized domain names (IDN) will be supported in the .SCA registry at the second level.

Domains in the Svenska Cellulosa Aktiebolaget SCA registry must be utilised solely for purposes that enhance Svenska Cellulosa Aktiebolaget SCA’s strategic or commercial interests. .SCA domains may not be used in a way which knowingly infringes any third party intellectual property rights or gives rise to moral or public order questions.

.SCA domain names may not be delegated or assigned to external organizations, institutions, or individuals.

All .SCA domains will carry accurate and up to date registration records.

The Svenska Cellulosa Aktiebolaget SCA Domain Name Management Team may revoke a .SCA domain name at any time in line with Svenska Cellulosa Aktiebolaget SCA’s corporate and strategic interests.

The Svenska Cellulosa Aktiebolaget SCA registry will be ICANN compliant: the registry will interface with the Trademark Clearinghouse, operate a Sunrise and IP Claims and all registrants must comply with the UDRP and the URS.


v. Will your proposed gTLD impose any measures for protecting the privacy of confidential information of registrants or users?

As a global organisation, we take our responsibility to protect the confidential information of customers and staff very seriously.

The .SCA registry will continue our policy of protecting confidential information and measures will be enhanced as now for existing domains. Svenska Cellulosa Aktiebolaget SCA will comply with the Personal Data obligations of the ICANN Registry Agreement and the European Union Data Protection Directive. As required, approved representatives will be registered as data handlers and trained to ensure compliance with ICANN’s requirements.

We will:

• Document policies and procedures including an escalation process
• Use appropriate levels of encryption and physical security
• Train key staff and ensure responsibilities are understood and documented in rules of conduct
• Limiting access to records only to those employees or service providers who need access for the performance of their job duties
• Test procedures
• Monitor best practice and ICANN’s mandated and recommended policies
• Audit the work of providers including the Escrow provider and checking data
• Report any attempts to gain unauthorised access to appropriate enforcement authorities as required by law

vi. Describe whether and in what ways outreach and communications will help to achieve your projected benefits?

We will produce and publish guidelines for internal use to provide clarity on how Svenska Cellulosa Aktiebolaget SCA representatives can apply for a .SCA domain together with how it is to be used. This is a standard registry closed to third parties. These guidelines should therefore ensure that .SCA domains are used in accordance with Svenska Cellulosa Aktiebolaget SCA’s objectives by authorised company representatives. We foresee the need to create a home page for the registry, for example, and will use clear and straightforward messaging. This is to ensure that our policy is clearly understood and complied with by our internal users. We will also participate in the ICANN Registry Operators Constituency.

gTLD	Full Legal Name	E-mail suffix	Detail
.TEVA	Teva Pharmaceutical Industries Limited	valideus.com	View

The registry will be stringently controlled by authorised Teva personnel and all registrants must have the Required License but it is predicted that it will also benefit the following stakeholders:
• Our customers: whether they are industry professionals or consumers, a new .Teva registry will benefit them by becoming a location for authentic, accessible information about the company and our products.
• Our employees: a new gTLD will reinforce our brand worldwide and provide a more secure communication channel.
• The free press and relevant governments. Since the .Teva registry will be a single entity registry, the free press and relevant governments will be able to take advantage of a single location for accurate information regarding the Teva.

What is the goal of your proposed gTLD in terms of areas of speciality, service levels reputation?

At Teva, we pride ourselves on the integrity of our brand and the high quality of our products. This will be reflected in the treatment of the new gTLD. Our goal is to position ourselves to exploit this latest internet advances in order to enhance our brand and reputation. We hope that our registry will be regarded by our customers as well as the investors who follow us and our peers in the pharma world, as the authentic location for accurate information on us and our work.

What do you anticipate your proposed gTLD will add to the current space in terms of competition, differentiation or innovation?

We are eager to operate a registry with shorter domain names that are universally applicable across the globe. We feel it offers clarity, simplicity and will enable our customers to place their trust in our registry while also providing potential for enhanced communication.

We look forward to utilising our new registry in conjunction with our current domains and are particularly keen to market under the term .Teva in future if the new gTLD process is a success. In enabling brands to leave behind complex naming hierarchies inherent in country code extensions, it accords with our culture of getting results by simplicity.

What goals does your proposed gTLD have in terms of user experience?

Regardless of their geographic location, we hope that our customers and others who visit to communicate with us, including investors, government, regulatory representatives and pharma experts, know they are in a trusted and authentic destination once they arrive at the new gTLD. We want them to be confident that they will receive accurate information and that their sensitive personal details will be protected.

Provide a complete description of the applicant’s intended registration policies in support of the goals above.

Teva is the operator of the .Teva registry. The Teva Domain Name Management team is responsible for the development, maintenance and enforcement of the Teva Domain Management Policy. This policy, which will be developed prior to launch, will define the rules associated with eligibility and domain name allocation, sets out the license terms governing the use of a .Teva domain name and describes the dispute resolution policies for the Teva gTLD. This policy will be updated and revised regularly to reflect Teva’s commercial and strategic interests and, where appropriate, ICANN consensus policies. The policy will restrict registration to only Teva and those who have the Required License.
Registration of a .Teva domain name will be undertaken in four steps: Eligibility Confirmation, Naming Convention Check, Acceptable Use Review, and finally Registration. All domains in the .Teva registry will remain the property of Teva. There will be no license right to use a domain name which is independent of the Required License.
Each applied for character string must conform to the .Teva rules of eligibility. Each .Teva name must:
• Be at least 3 characters and no more than 63 characters long
• Not contain a hyphen on the 3rd and 4th position (tagged domains)
• Contain only letters (a-z), numbers (0-9) and hyphens or a combination of these
• Start and end with an alphanumeric character, not a hyphen
• Not match any character strings reserved by ICANN
• Not match any protected country names or geographical terms
Internationalized domain names (IDN) will be supported in the .Teva registry at the second level.
All .Teva names must be utilised solely for purposes that enhance Teva’s strategic or commercial interests. .Teva domains may not be used in a way which knowingly infringes any third party intellectual property rights or gives rise to moral or public order questions.
.Teva domain names may not be delegated or assigned to external organizations, institutions, or individuals.
All .Teva domains will carry accurate and up to date registration records.
The Teva Domain Name Management Team may revoke a .Teva domain name at any time in line with Teva’s corporate and strategic interests.
The Teva registry will be ICANN compliant: the registry will interface with the Trademark Clearinghouse, operate a Sunrise and IP Claims and all registrants must comply with the UDRP and the URS,among other consensus policies.

Will your proposed gTLD impose any measures for protecting the privacy of confidential information of registrants or users?

As a global generic pharmaceuticals company, we take our responsibility to protect the confidential information of customers and staff very seriously.

The .Teva registry will continue our policy of protecting confidential information. Teva will comply with the Personal Data obligations of the ICANN Registry Agreement and it will meet standards such as those laid down in the European Union Data Protection Directive. As required, approved representatives will be registered as data handlers and trained to ensure compliance with ICANN’s requirements.
We will:
• Document policies and procedures including an escalation process
• Use appropriate levels of encryption and physical security
• Train key staff and ensuring responsibilities are understood and documented in rules of conduct
• Limit access to records only to those employees or service providers who need access for the performance of their job duties
• Test procedures
• Monitor best practice and ICANN’s mandated and recommended policies
• Audit the work of providers including the Escrow provider and checking data.

Describe whether and in what ways outreach and communications will help to achieve your projected benefits?

We will produce and publish guidelines for internal use. These are intended to provide clarity on who can qualify to register a .Teva domain and how it is to be used. As mentioned above, this is a standard registry closed to third parties that do not have the Required License so these guidelines should ensure that .Teva domains are used in accordance with Teva’s objectives by authorised Teva representatives. For example, it will be necessary to create a home page for the registry using straightforward messaging for the benefit of internal users so that our policies and the rules of eligibility are clearly understood.